ArticleViruses2021

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.

Michael A Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.